Abstract:An 8-week feeding trial was conducted to investigate the effects of dietary fucoidan levels (0 mg/kg, 500 mg/kg, 1,000 mg/kg, 1,500 mg/kg, and 2,000 mg/kg) on the hepatic ultrastructure and the transcriptomic landscape within the liver tissue of common carp. The results revealed that the addition of 1,000 mg/kg fucoidan to the diet significantly altered the ultrastructure of hepatocytes. Notably, the quantities of lipid droplets, autolysosomes, enlarged mitochondria, and endoplasmic reticulum were increased in the hepatocytes. The liver transcriptome analysis revealed that DEGs were notably abundant in the 1,000-mg/kg fucoidan group in glucolipid metabolism signaling pathways, including eukaryotes and nicotinate and nicotinamide metabolism, steroid biosynthesis, and PPAR signaling pathways. The quantitative real-time PCR (qPCR) results showed an excellent agreement on those of RNA-seq for both up- and down-regulated genes (a total of 13 genes selected for validation). Furthermore, fucoidan significantly influenced hepatic glucolipid metabolism of common carp at the mRNA level. Notably, the inclusion of lower concentrations of fucoidan in the diet, specifically at 500 mg/kg and 1,000 mg/kg, was found to significantly enhance the expression of mRNA for genes involved in glycolysis, including hk, gk, and pk, as well as genes linked to lipogenesis, such as srebf1, fasn, elovl5, acsl3a, scd, fads2, and cyp24a1. Conversely, higher concentrations of dietary fucoidan, at 1,500 mg/kg and 2,000 mg/kg, were observed to markedly upregulate the mRNA expression of genes associated with gluconeogenesis, including pck1, pck2, gs, gsk3a, gsk3b, and g6pca.1, along with genes related to lipolysis, such as hadhb, acadl, ecil, acacba, cpt1, fabp1, and fabp3. In summary, varying levels of fucoidan intake appear to exert differential influences on the hepatic glucolipid metabolism of common carp, suggesting a complex dose-dependent regulatory mechanism. For the first time, this research has established that fucoidan possesses a pronounced regulatory influence on the hepatic glucolipid metabolism in fish. This discovery not only underscores its potential as an immunostimulant but also opens new avenues for its application as a feed additive, with implications for modulating the nutritional metabolism of aquatic species.

Pharmacokinetics of fucoidan and low molecular weight fucoidan from Saccharina japonica after oral administration to mice

Comparative Study of Fucoidan from <i>Saccharina japonica</i> and Its Depolymerized Fragment on Adriamycin-Induced Nephrotic Syndrome in Rats

A comparative study of the hypolipidemic effects and mechanisms of action of Laminaria japonica - and Ascophyllum nodosum -derived fucoidans in apolipoprotein E-deficient mice

Orally administrated fucoidan and its low-molecular-weight derivatives are absorbed differentially to alleviate coagulation and thrombosis

Dietary Supplementation with Low-Molecular-Weight Fucoidan Enhances Innate and Adaptive Immune Responses and Protects against Mycoplasma pneumoniae Antigen Stimulation

Potential antioxidant and anticoagulant capacity of low molecular weight fucoidan fractions extracted from Laminaria japonica

Fucoidans from Pearsonothuria Graeffei Prevent Obesity by Regulating Intestinal Lipid Metabolism and Inflammation Related Signalling Pathways

Extraction, purification, structural characterization and anti-hyperlipidemia activity of fucoidan from Laminaria digitata

In vitro and in vivo immunomodulatory effects of fucoidan compound agents

Comparative study of the immunomodulatory effects of different fucoidans from Saccharina japonica mediated by scavenger receptors on RAW 264.7 macrophages

Molecular Mechanism of Anti-Inflammatory Activities of a Novel Sulfated Galactofucan from Saccharina japonica

A comprehensive review to assess the potential, health benefits and complications of fucoidan for developing as functional ingredient and nutraceutical

Effect and mechanism of fucoidan derivatives from Laminaria japonica in experimental adenine-induced chronic kidney disease

Fucoidan Changes Lipid Accumulation in the Liver of Common Carp (cyprinus Carpio) by Modulating Lipid and Glucose Metabolism

In Vitro Anti-Inflammatory Activities of Fucoidans from Five Species of Brown Seaweeds

Hypoglycemic property of acidic polysaccharide extracted from Saccharina japonica and its potential mechanism

Saccharina japonica fucan suppresses high fat diet-induced obesity and enriches fucoidan-degrading gut bacteria

Bioactivity of fucoidan extracted from Laminaria japonica using a novel procedure with high yield

A comparative study of the effects of different fucoidans on cefoperazone-induced gut microbiota disturbance and intestinal inflammation

Biological Activities of Fucoidan and the Factors Mediating Its Therapeutic Effects: A Review of Recent Studies